Cite
HARVARD Citation
Kraeber-Bodere, F. et al. (2017). Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial. Lancet. 4 (1), pp. e35-e45. [Online].